Dec 12, 2024 8:00am EST 180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules
Dec 04, 2024 8:00am EST 180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors
Oct 31, 2024 8:00am EDT 180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform Integration
Oct 16, 2024 8:00am EDT 180 Life Sciences Corp. Interim CEO, Blair Jordan, Issues Letter to Stockholders; Provides Update on Newly Acquired Gaming Technology Platform
Oct 09, 2024 8:30am EDT 180 Life Sciences Corp. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Rule and Expands into the Global iGaming Sector
Sep 12, 2024 4:15pm EDT 180 Life Sciences Announces the Appointment of Omar Jimenez as Chief Financial Officer
Jul 30, 2024 8:00am EDT 180 Life Sciences Announces Positive Topline Results of a Clinical Pharmacology Study Testing a New Solid Formulation of CBD with Enhanced Oral Uptake
Jul 23, 2024 8:00am EDT 180 Life Sciences Granted an Additional Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements